Terms: = Prostate cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
40 results:
1. A Machine Learning Method for Predicting Biomarkers Associated with prostate cancer.
Tong Y; Tan Z; Wang P; Gao X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):333. PubMed ID: 38179769
[TBL] [Abstract] [Full Text] [Related]
2. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract] [Full Text] [Related]
3. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation.
Zhang P; Chen L; Zhou F; He Z; Wang G; Luo Y
Cell Death Dis; 2023 Feb; 14(2):159. PubMed ID: 36841806
[TBL] [Abstract] [Full Text] [Related]
4. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract] [Full Text] [Related]
5. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer.
Lopez de Rodas M; Nagineni V; Ravi A; Datar IJ; Mino-Kenudson M; Corredor G; Barrera C; Behlman L; Rimm DL; Herbst RS; Madabhushi A; Riess JW; Velcheti V; Hellmann MD; Gainor J; Schalper KA
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35649657
[TBL] [Abstract] [Full Text] [Related]
6. The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells.
Nicolai A; Taurone S; Carradori S; Artico M; Greco A; Costi R; Scarpa S
Invest New Drugs; 2022 Jun; 40(3):556-564. PubMed ID: 35312942
[TBL] [Abstract] [Full Text] [Related]
7. A pan-cancer analysis based on weighted gene co-expression network analysis identifies the biomarker utility of lamin B1 in human tumors.
Hua Y; He Z; Zhang X
Cancer Biomark; 2022; 34(1):23-39. PubMed ID: 34511484
[TBL] [Abstract] [Full Text] [Related]
8. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
Wang Y; Wang J; Tang Q; Ren G
PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
[TBL] [Abstract] [Full Text] [Related]
9. Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Armstrong AJ; Nixon AB; Carmack A; Yang Q; Eisen T; Stadler WM; Jones RJ; Garcia JA; Vaishampayan UN; Picus J; Hawkins RE; Hainsworth JD; Kollmannsberger CK; Logan TF; Puzanov I; Pickering LM; Ryan CW; Protheroe A; George DJ; Halabi S
Clin Cancer Res; 2021 Jun; 27(12):3317-3328. PubMed ID: 33593885
[TBL] [Abstract] [Full Text] [Related]
10. Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients.
Luo F; Han J; Chen Y; Yang K; Zhang Z; Li J
Future Oncol; 2021 Feb; 17(6):663-673. PubMed ID: 33112662
[No Abstract] [Full Text] [Related]
11. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract] [Full Text] [Related]
12. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis.
Cheng Y; Li L; Qin Z; Li X; Qi F
J Cell Mol Med; 2020 Jul; 24(14):8006-8017. PubMed ID: 32485038
[TBL] [Abstract] [Full Text] [Related]
13. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in lung adenocarcinoma: A STROBE compliant article.
Feng H; Wang M; Wu C; Yu J; Wang D; Ma J; Han J
Medicine (Baltimore); 2018 Mar; 97(13):e0203. PubMed ID: 29595658
[TBL] [Abstract] [Full Text] [Related]
14. Metformin Has Positive Therapeutic Effects in Colon cancer and Lung cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract] [Full Text] [Related]
15. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.
Bonamichi-Santos R; Castells M
Clin Rev Allergy Immunol; 2018 Jun; 54(3):375-385. PubMed ID: 27277133
[TBL] [Abstract] [Full Text] [Related]
16. Low LKB1 Expression Results in Unfavorable prognosis in prostate cancer Patients.
Lu J; Sun P; Sun B; Wang C
Med Sci Monit; 2015 Nov; 21():3722-7. PubMed ID: 26616116
[TBL] [Abstract] [Full Text] [Related]
17. GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer.
Naiki T; Naiki-Ito A; Asamoto M; Kawai N; Tozawa K; Etani T; Sato S; Suzuki S; Shirai T; Kohri K; Takahashi S
Carcinogenesis; 2014 Sep; 35(9):1962-7. PubMed ID: 24562575
[TBL] [Abstract] [Full Text] [Related]
18. Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature.
Ambrosio MR; Rocca BJ; Onorati M; Bellan C; Barbanti G; del Vecchio MT; Tripodi S
Histol Histopathol; 2012 Oct; 27(10):1327-32. PubMed ID: 22936451
[TBL] [Abstract] [Full Text] [Related]
19. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Zlobec I; Minoo P; Terracciano L; Baker K; Lugli A
Histopathology; 2011 Sep; 59(3):482-95. PubMed ID: 22034888
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia signature of splice forms of tryptophanyl-tRNA synthetase marks pancreatic cancer cells with distinct metastatic abilities.
Paley EL; Paley DE; Merkulova-Rainon T; Subbarayan PR
Pancreas; 2011 Oct; 40(7):1043-56. PubMed ID: 21926542
[TBL] [Abstract] [Full Text] [Related]
[Next]